AMER ABDULGHAFOOR: Open Payments
NPI 1619401718 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,382 in 101 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $408 · 2025 $2,382
Food & beverage: $2,382
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 39 | $961 |
| Gilead Sciences, Inc. | 26 | $604 |
| Theratechnologies Inc. | 8 | $210 |
| Merck Sharp & Dohme LLC | 7 | $160 |
| Seqirus USA Inc | 2 | $56 |
| Exact Sciences Corporation | 2 | $50 |
| Novo Nordisk Inc | 2 | $44 |
| Indivior Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Napo Pharmaceuticals Inc | 2 | $32 |
Products named: DOVATO, CABENUVA, APRETUDE, EGRIFTA, Biktarvy, CAPVAXIVE, RUKOBIA, Cologuard Collection Kit.
Industry payments across IL — which companies pay providers there.
